AcelRx Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $1.83 | $1.32 | $1.58 |
| Q2 2024 | 0 | $1.56 | $1.13 | $1.34 |
| Q3 2024 | 0 | $1.79 | $1.29 | $1.54 |
AcelRx Pharmaceuticals, Inc. Earnings Date And Information
AcelRx Pharmaceuticals, Inc. last posted its earnings results on Wednesday, November 8th, 2023. The company reported $-0.08 earnings per share for the quarter, topping analysts' consensus estimates of $-0.29 by $0.21. The company had revenue of 117,000 for the quarter and had revenue of 651,000 for the year. AcelRx Pharmaceuticals, Inc. has generated $0 earnings per share over the last year ($-0.0007 diluted earnings per share) and currently has a price-to-earnings ratio of -2.52. AcelRx Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 27th, 2024 based on prior year's report dates.
AcelRx Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2023 | Q3 2023 | -$0.08 | $263,000 | $117,000 | ||
| 08/10/2023 | Q2 2023 | -$0.53 | -$0.40 | 0.13 | $70,000 | $253,000 |
| 05/10/2023 | Q1 2023 | -$0.80 | $0.49 | 1.29 | $0 | |
| 03/31/2023 | Q4 2022 | -$1.01 | $252,000 | |||
| 11/14/2022 | Q3 2022 | -$1.20 | -$0.91 | 0.29 | $2.38 M | $507,000 |
| 08/11/2022 | Q2 2022 | -$1.20 | $9.60 | 10.8 | $442,000 | $570,000 |
| 05/16/2022 | Q1 2022 | -$1.20 | -$1.15 | 0.05 | $442,000 | |
| 03/10/2022 | Q4 2021 | -$1.20 | -$1.24 | -0.04 | $2,000 | |
| 11/15/2021 | Q3 2021 | -$1.40 | -$1.40 | 0 | $1.90 M | $1.86 M |
| 08/16/2021 | Q2 2021 | -$1.60 | -$1.65 | -0.05 | $511,000 | $443,000 |
| 05/17/2021 | Q1 2021 | -$1.60 | -$1.58 | 0.02 | $511,000 | |
| 03/15/2021 | Q4 2020 | -$2.40 | -$1.93 | 0.47 | $738,000 | |
| 11/05/2020 | Q3 2020 | -$1.40 | -$2.03 | -0.63 | $1.37 M | |
| 08/10/2020 | Q2 2020 | -$2.80 | -$1.64 | 1.16 | $5.12 M | $2.92 M |
| 05/11/2020 | Q1 2020 | -$3.00 | -$3.98 | -0.98 | $386,000 | |
| 03/16/2020 | Q4 2019 | -$4.40 | -$3.63 | 0.77 | $475,000 | |
| 11/06/2019 | Q3 2019 | -$3.20 | $836,000 | $608,000 | ||
| 08/05/2019 | Q2 2019 | -$3.15 | $1.29 M | $941,000 | ||
| 05/09/2019 | Q1 2019 | -$3.47 | $265,000 | |||
| 03/07/2019 | Q4 2018 | -$4.00 | -$3.56 | 0.44 | $613,000 |
AcelRx Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is AcelRx Pharmaceuticals, Inc.'s earnings date?
AcelRx Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 27th, 2024 based off last year's report dates.
-
Did AcelRx Pharmaceuticals, Inc. beat their earnings estimates last quarter?
In the previous quarter, AcelRx Pharmaceuticals, Inc. (:ACRX) reported $-0.08 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.29 by $0.21.
-
How can I listen to AcelRx Pharmaceuticals, Inc.'s earnings conference call?
The conference call for AcelRx Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read AcelRx Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for AcelRx Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much revenue does AcelRx Pharmaceuticals, Inc. generate each year?
AcelRx Pharmaceuticals, Inc. (:ACRX) has a recorded annual revenue of $651,000.
-
How much profit does AcelRx Pharmaceuticals, Inc. generate each year?
AcelRx Pharmaceuticals, Inc. (:ACRX) has a recorded net income of $651,000. AcelRx Pharmaceuticals, Inc. has generated $-0.0007 earnings per share over the last four quarters.
-
What is AcelRx Pharmaceuticals, Inc.'s price-to-earnings ratio?
AcelRx Pharmaceuticals, Inc. (:ACRX) has a price-to-earnings ratio of -2.52 and price/earnings-to-growth ratio is -0.06.
